These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6258881)

  • 1. Pulmonary angiotensin-converting enzyme and its inhibition: a historical survey.
    Bakhle YS
    Ciba Found Symp; 1980; 78():275-92. PubMed ID: 6258881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
    Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
    Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
    Komori T; Takada T; Funae Y; Yamamoto K
    Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications.
    Unger T; Ganten D; Lang RE
    Am J Cardiol; 1987 Apr; 59(10):18D-22D. PubMed ID: 3034027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
    Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
    Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of angiotensin converting enzyme inhibitors. A review.
    Nelson EB; Pool JL; Taylor AA
    Am J Med; 1986 Oct; 81(4C):13-8. PubMed ID: 3022580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
    Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
    Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of pulmonary angiotensin-converting enzyme and 5'-nucleotidase in vivo.
    Catravas JD; White RE
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Oct; 57(4):1173-81. PubMed ID: 6094404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of either angiotensin-converting enzyme or neutral endopeptidase induces both enzymes.
    Helin K; Tikkanen I; Hohenthal U; Fyhrquist F
    Eur J Pharmacol; 1994 Oct; 264(2):135-41. PubMed ID: 7851475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27.
    Montgomery HE; Kiernan LA; Whitworth CE; Fleming S; Unger T; Gohlke P; Mullins JJ; McEwan JR
    J Hypertens; 1998 May; 16(5):635-43. PubMed ID: 9797175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive effect of SA446, an angiotensin converting enzyme inhibitor, in 2-kidney, 1-clip renal hypertensive and normotensive dogs.
    Nishimura K; Miyazaki M; Okunishi H; Toda N
    Jpn J Pharmacol; 1987 Apr; 43(4):379-87. PubMed ID: 3039218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of ketomethylene-containing nonapeptide analogues of snake venom angiotensin converting enzyme inhibitors.
    Almquist RG; Chao WR; Judd AK; Mitoma C; Rossi DJ; Panasevich RE; Matthews RJ
    J Med Chem; 1988 Mar; 31(3):561-7. PubMed ID: 2831364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
    Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats.
    Suzuki M; Satoh S
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):121-36. PubMed ID: 6275810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of [3H]captopril binding by peptide analog angiotensin converting enzyme inhibitors.
    Toll L; Almquist RG
    Biochem Biophys Res Commun; 1986 Mar; 135(3):770-7. PubMed ID: 3008745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic administration of an angiotensin-converting enzyme inhibitor on angiotensin-converting enzyme activity in the pars recta of rabbits.
    Praddaude F; Tran-Van T; Marchetti J; Girolami JP; Ader JL
    Clin Sci (Lond); 1990 Jul; 79(1):29-35. PubMed ID: 2167787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of angiotensin I to angiotensin II.
    Erdös EG
    Am J Med; 1976 May; 60(6):749-59. PubMed ID: 190881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.